Synbio Tech (ROCO:1295) Other Current Liabilities: NT$25 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:1295 Synbio Tech Inc ROCO:1295
42 GF Score
Price NT$46.60
! 9 Warning Signs
View Full Analysis

What is Synbio Tech Other Current Liabilities?

Synbio Tech ROCO:1295 +0.87% 42 Other Current Liabilities is NT$25 Mil as of Mar. 2026. GuruFocus rates ROCO:1295 with a GF Score™ of 42/100. The stock has 9 warning signs investors should review.

Synbio Tech's other current liabilities for the quarter that ended in Mar. 2026 was NT$25 Mil.

Synbio Tech's quarterly other current liabilities declined from Sep. 2025 (NT$22 Mil) to Dec. 2025 (NT$20 Mil) but then increased from Dec. 2025 (NT$20 Mil) to Mar. 2026 (NT$25 Mil).

Synbio Tech's annual other current liabilities declined from Dec. 2023 (NT$26 Mil) to Dec. 2024 (NT$23 Mil) and declined from Dec. 2024 (NT$23 Mil) to Dec. 2025 (NT$20 Mil).

Synbio Tech Other Current Liabilities Related Terms

Synbio Tech Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Synbio Tech's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Synbio Tech Other Current Liabilities Chart

Synbio Tech Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Liabilities
Get a 7-Day Free Trial 12.42 15.83 26.24 22.70 19.88

Synbio Tech Quarterly Data
Dec20 Dec21 Dec22 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 25.22 19.72 21.80 19.88 24.59
ROCO:1295
42GF Score
Synbio Tech Inc ROCO:1295
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Synbio Tech Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of NT$25 Mil mean?
Synbio Tech (ROCO:1295) has a Other Current Liabilities of NT$25 Mil as of Mar. 2026. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Synbio Tech.
Is Synbio Tech's Other Current Liabilities too high?
Synbio Tech's current Other Current Liabilities is NT$25 Mil. Overall, Synbio Tech has a GF Score™ of 42/100, reflecting its overall financial health beyond just this single metric.
How does Synbio Tech's Other Current Liabilities compare to VRTX and REGN?
Synbio Tech's Other Current Liabilities of NT$25 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Biotechnology company?
A good Other Current Liabilities depends on the Biotechnology industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Synbio Tech. Synbio Tech's current Other Current Liabilities is NT$25 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Synbio Tech stock overvalued right now?
Synbio Tech (ROCO:1295) has a current Other Current Liabilities of NT$25 Mil. The current Other Current Liabilities is NT$25 Mil. Synbio Tech's overall GF Score™ is 42/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Synbio Tech (ROCO:1295), the current Other Current Liabilities is NT$25 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Synbio Tech Business Description

Address No.82, Beiling 6th Road, Luzhu District, Kaohsiung, TWN, 821
Synbio Tech Inc focus on functional research and manufacturing of probiotics for human health and economic animals. It has two reportable segments, Taiwan and Mainland China Segment to engage in the production and R&D technologies of the Taiwan Segment, including the production and sales of concentrated fermentation liquid, lactobacillus plantarum solid drinks, and lactobacillus plantarum granules for animal husbandry. It generates majority of revenue from Taiwan segment includes production and sale of lactobacillus plantarum powder, lactobacillus plantarum fermentation derivative products, probiotics dietary supplements, probiotics products for pets and economic animals, and probiotics products. It has presence in Taiwan, China, Southeast Asia, and Others.
42GF Score

Get the complete analysis for ROCO:1295

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$46.60
Price